Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saint Bella GroupHKSE:02508 -1.37%13 EBITDA Margin % is 20.49% as of Dec. 2025. GuruFocus rates HKSE:02508 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Saint Bella Group ranks better than 97.28% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Saint Bella Group's EBITDA for the
six
months ended in Dec. 2025 was HK$135 Mil. Saint Bella Group's Revenue for the
six
months ended in Dec. 2025 was HK$659 Mil. Therefore, Saint Bella Group's EBITDA margin for the quarter that ended in Dec. 2025 was 20.49%.
Saint Bella Group (HKSE:02508) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Saint Bella Group EBITDA Margin % Related Terms
Saint Bella Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Saint Bella Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02508 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Saint Bella Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saint Bella Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Saint Bella Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Saint Bella Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saint Bella Group (HKSE:02508) has a EBITDA Margin % of 20.49% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Saint Bella Group and its competitors. According to the industry distribution chart, Saint Bella Group ranks #18 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 2.7%.
Is Saint Bella Group's EBITDA Margin % too high?
Saint Bella Group's current EBITDA Margin % is 20.49%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Saint Bella Group's value of 20.49% is 100.7% above this industry median. Based on the distribution chart, Saint Bella Group ranks #18 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Saint Bella Group has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Saint Bella Group's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Saint Bella Group ranks #18 out of 662 companies for EBITDA Margin %. This places Saint Bella Group in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Saint Bella Group's value of 20.49% is 100.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saint Bella Group's current EBITDA Margin % of 20.49% is 100.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Saint Bella Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saint Bella Group's current EBITDA Margin % is 20.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saint Bella Group stock overvalued right now?
Saint Bella Group (HKSE:02508) has a current EBITDA Margin % of 20.49%. The current EBITDA Margin % is 20.49% and 100.7% above the Healthcare Providers & Services industry median of 10.21. Saint Bella Group's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Saint Bella Group (HKSE:02508), the current EBITDA Margin % is 20.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Saint Bella Group Ltd is a postpartum care and recovery group in China, and it also offer home care services and food products covering women's needs. Its activities include postpartum center business (including postpartum care services and postpartum recovery services); home care services business; and food product business. Geographically it operates in the PRC, Hong Kong, Singapore and the United States.
13GF Score
Get the complete analysis for HKSE:02508
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02508 has been successfully added to your 
